# Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

> **NCT01181063** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/formoterol 320/9 μg and 400/12 μg inhalers

## Key facts

- **NCT ID:** NCT01181063
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181063, "Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*